Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103933062 | 10393306 | 2 | F | 2014 | 20160919 | 20140819 | 20160922 | EXP | US-PFIZER INC-2014227316 | PFIZER | 58.00 | YR | M | Y | 72.56000 | KG | 20160922 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103933062 | 10393306 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 50 MG, 2X/DAY | V120519 | 21446 | 50 | MG | CAPSULE, HARD | BID | |||||
| 103933062 | 10393306 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 50MG IN THE MORNING AND 100MG AT NIGHT | 21446 | CAPSULE, HARD | BID | ||||||||
| 103933062 | 10393306 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, 2X/DAY (BY TAKING 2 CAPSULES OF 50MG) | 21446 | 100 | MG | CAPSULE, HARD | BID | ||||||
| 103933062 | 10393306 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 100MG IN THE MORNING, 50MG IN THE AFTERNOON AND 100MG AT NIGHT | 21446 | CAPSULE, HARD | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103933062 | 10393306 | 1 | Complex regional pain syndrome |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103933062 | 10393306 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103933062 | 10393306 | Abasia | |
| 103933062 | 10393306 | Arthralgia | |
| 103933062 | 10393306 | Arthropathy | |
| 103933062 | 10393306 | Back pain | |
| 103933062 | 10393306 | Diplopia | |
| 103933062 | 10393306 | Dry eye | |
| 103933062 | 10393306 | Limb discomfort | |
| 103933062 | 10393306 | Mental impairment | |
| 103933062 | 10393306 | Movement disorder | |
| 103933062 | 10393306 | Ocular hyperaemia | |
| 103933062 | 10393306 | Pain in extremity | |
| 103933062 | 10393306 | Peripheral swelling | |
| 103933062 | 10393306 | Thinking abnormal | |
| 103933062 | 10393306 | Vision blurred | |
| 103933062 | 10393306 | Visual field defect | |
| 103933062 | 10393306 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103933062 | 10393306 | 1 | 201311 | 201311 | 0 | |
| 103933062 | 10393306 | 2 | 201311 | 0 | ||
| 103933062 | 10393306 | 3 | 201407 | 0 | ||
| 103933062 | 10393306 | 4 | 201407 | 0 |